On-Demand Webcast

Share

Program Content

Activities

  • HCC Systemic Treatment
    Systemic Treatment for Hepatobiliary Cancers in First and Later Lines: Applying the Latest Data
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 21, 2022

    Expires: December 20, 2023

Faculty

cover img faculity

James M. Cleary, MD, PhD

Associate Professor of Medicine
Harvard Medical School
Director of Clinical Research
Gastrointestinal Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

AstraZeneca

Genentech, a member of the Roche Group